The European Medicines Agency on Tuesday said it would hold an extraordinary meeting on December 29 to consider emergency approval for a vaccine developed by Germany’s BioNTech and US giant Pfizer
from The Hindu - News https://ift.tt/36rzk4z
Copyright (c) 2020 the india mirror news All Right Reseved
Social Plugin